Black Diamond Therapeutics
BDTX
BDTX
59 hedge funds and large institutions have $37.8M invested in Black Diamond Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-9
Holders Change %
-13.24%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
26
Closed
18
Calls
$50K
Puts
$77K
Net Calls
-$27K
Net Calls Change
-$64K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.32M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.23M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$508K |
| 4 |
Millennium Management
New York
|
+$320K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$95K |
Top Sellers
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$1.57M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$544K |
| 3 |
BlackRock
New York
|
-$486K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$389K |
| 5 |
Morgan Stanley
New York
|
-$356K |
